The drugstores allege it was the doctors who prescribed the pills who should shoulder the culpability for the opioid crisis.
News & Analysis: Rite Aid
The company needs the right traffic-driving plans and flawless execution.
Investors appear to be taking profits off the table after last week's huge gains.
Markets were little changed to finish the quiet holiday week.
Here's why Rite Aid could be rising Thursday morning, and what investors should keep in mind.
Shares were rallying following a strong earnings report.
A big earnings beat and better-than-expected guidance led to a big day for the pharmacy retail stock.
RAD earnings call for the period ending November 30, 2019.
Major benchmarks kept moving higher despite events in Washington.
Better-than-expected Q3 results have investors fired up.